SCHEMBL14082234

SCHEMBL14082234

Cc1ccc(/C=N/NC(=O)CNc2cccc3ccccc23)cc1Br

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 13/20 0.67
▸ MEN1 O00255 11/20 0.67
▸ KMT2A Q03164 11/20 0.67
▸ MCL1 Q07820 1/20 0.67
▸ KDM4E B2RXH2 6/20 0.65
▸ ALDH1A1 P00352 2/20 0.63
▸ LMNA P02545 3/20 0.62
▸ TDP1 Q9NUW8 2/20 0.62
▸ SMN1; SMN2 Q16637 1/20 0.62
▸ NPC1 O15118 1/20 0.59
▸ RAB9A P51151 1/20 0.59
▸ MAPK1 P28482 2/20 0.59
▸ CYP1A2 P05177 1/20 0.57
▸ CYP2C9 P11712 1/20 0.57
▸ CYP2C19 P33261 1/20 0.57
▸ NPSR1 Q6W5P4 1/20 0.57
▸ MITF O75030 1/20 0.55
▸ NOD2 Q9HC29 1/20 0.55
▸ POLB P06746 3/20 0.54
▸ HTT P42858 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14082221 0.90 MAPT (0.66) MAPTMEN1KMT2AMCL1KDM4E
SCHEMBL12648540 0.89 MAPT (0.67) MAPTMEN1KMT2AMCL1KDM4E
SCHEMBL12648526 0.87 MAPT (0.66) MAPTMEN1KMT2AMCL1KDM4E
SCHEMBL14082218 0.81 MEN1 (0.60) MAPTMEN1KMT2AMCL1KDM4E
SCHEMBL12648531 0.79 CFTR (0.69) MAPTMEN1KMT2AMCL1KDM4E
SCHEMBL12872564 0.76 MAPT (0.52) MAPTMEN1KMT2AMCL1KDM4E
SCHEMBL17080646 0.74 KMT2A (0.69) MAPTMEN1KMT2AMCL1KDM4E
SCHEMBL14082172 0.72 MAPT (0.53) MAPTMEN1KMT2AMCL1KDM4E
SCHEMBL14082217 0.72 MEN1 (0.67) MAPTMEN1KMT2AMCL1KDM4E
SCHEMBL15521408 0.72 MAPT (0.61) MAPTMEN1KMT2AMCL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414037-B2 cystic fibrosis transmembrane conductance regulator protein inhibitor; 2-naphthalenylamino-[(3,5-dibromo-2,4-dihydroxyphenyl)methylene][3-[4-(3-(PEG)n-thioureido)diphenyl)-thioureido]propanedioic acid dihydrazide (MalH-(PEG)nB); cystic fibrosis with forms of male infertility, secretory diarrhea THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-08-19 — — US disclosed
Send feedback